TP53 and thyroid gland undifferentiated (anaplastic) carcinoma: For instance, introducing wild-type p53 into the anaplastic thyroid cancer-derived ARO cell line (which harbors mutated p53) significantly reduced cell proliferation and increased the proportion of cells in the G0/G1 phase.